BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives

15 September 2021, Zwingenberg (Germany) - The Management Board of BRAIN Biotech AG has, with the approval of the Supervisory Board, successfully completed the issue of approximately 1.99 million new shares (corresponding to approx. 10% of the share capital) as part of a cash capital increase from authorised capital excluding subscription rights.